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Circulation
CONSENSUS REPORTS
Interim Guidance for Basic and Advanced Life Support in Adults,
Children, and Neonates With Suspected or Confirmed COVID-19
From the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and
Pediatric Task Forces of the American Heart Association
In Collaboration With the American Academy of Pediatrics, American Association for Respiratory Care, American College of Emergency Physicians,
The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists
Supporting Organizations: American Association of Critical Care Nurses and National Association of EMS Physicians

E

xisting American Heart Association cardiopulmonary resuscitation (CPR)
guidelines do not address the challenges of providing resuscitation in the
setting of the coronavirus disease 2019 (COVID-19) global pandemic,
wherein rescuers must continuously balance the immediate needs of the patients with their own safety. To address this gap, the American Heart Association, in collaboration with the American Academy of Pediatrics, American
Association for Respiratory Care, American College of Emergency Physicians,
The Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists, and with the support of the American Association of Critical
Care Nurses and National Association of EMS Physicians, has compiled interim
guidance to help rescuers treat individuals with cardiac arrest with suspected
or confirmed COVID-19.
Over the past 2 decades, there has been a steady improvement in survival
after cardiac arrest occurring both inside and outside the hospital.1 That success
has relied on initiating proven resuscitation interventions such as high-quality
chest compressions and defibrillation within seconds to minutes. The evolving
and expanding outbreak of severe acute respiratory syndrome coronavirus 2
infections has created important challenges to such resuscitation efforts and
requires potential modifications of established processes and practices. The
challenge is to ensure that patients with or without COVID-19 who experience
cardiac arrest get the best possible chance of survival without compromising the
safety of rescuers, who will be needed to care for future patients. Complicating
the emergency response to both out-of-hospital and in-hospital cardiac arrest
is that COVID-19 is highly transmissible, particularly during resuscitation, and
carries a high morbidity and mortality.
Approximately 12% to 19% of COVID-positive patients require hospital admission, and 3% to 6% become critically ill.2–4 Hypoxemic respiratory failure secondary
to acute respiratory distress syndrome, myocardial injury, ventricular arrhythmias,
and shock are common among critically ill patients and predispose them to cardiac
arrest,5–8 as do some of the proposed treatments such as hydroxychloroquine and
azithromycin, which can prolong the QT.9 With infections currently growing exponentially in the United States and internationally, the percentage of patients with
cardiac arrests and COVID-19 is likely to increase.
Healthcare workers are already the highest-risk profession for contracting the
disease.10 This risk is compounded by worldwide shortages of personal protective equipment (PPE). Resuscitations carry added risk to healthcare workers for
many reasons. First, the administration of CPR involves performing numerous
aerosol-generating procedures, including chest compressions, positive-pressure
ventilation, and establishment of an advanced airway. During those procedures,
viral particles can remain suspended in the air with a half-life of ≈1 hour and
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be inhaled by those nearby.11 Second, resuscitation
efforts require numerous providers to work in close
proximity to one another and the patient. Finally,
these are high-stress emergency events in which the
immediate needs of the patient requiring resuscitation may result in lapses in infection-control practices.
In arriving at this interim guidance, we reviewed
existing American Heart Association CPR recommendations in the context of the COVID-19 pandemic and
considered the unique pathophysiology of COVID-19
with reversal of hypoxemia as a central goal. We sought
to balance the competing interests of providing timely
and high-quality resuscitation to patients and simultaneously protecting rescuers. This statement applies to
all adult, pediatric, and neonatal resuscitations in patients with suspected or confirmed COVID-19 infection
unless otherwise noted. The guidance contained herein
is based on expert opinion and needs to be adapted
locally on the basis of current disease burden and resource availability.

GENERAL PRINCIPLES FOR
RESUSCITATION IN PATIENTS WITH
SUSPECTED AND CONFIRMED
COVID-19
Reduce Provider Exposure to COVID-19
Rationale
It is essential that providers protect themselves and
their colleagues from unnecessary exposure. Exposed
providers who contract COVID-19 further decrease the
already strained workforce available to respond and
have the potential to add additional strain if they become critically ill.
Strategies
1. Before entering the scene, all rescuers should don
PPE to guard against contact with both airborne
and droplet particles. Consult individual health or
emergency medical services (EMS) system standards because PPE recommendations may vary
considerably on the basis of current epidemiological data and availability.
2. Limit personnel in the room or on the scene to
only those essential for patient care.
3. In settings with protocols in place and expertise in
their use, consider replacing manual chest compressions with mechanical CPR devices to reduce
the number of rescuers required for adults and
adolescents who meet the manufacturer’s height
and weight criteria.
4. Clearly communicate COVID-19 status to any
new providers before their arrival on the scene
or receipt of the patient when transferring to a
second setting.
e934
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Prioritize Oxygenation and Ventilation
Strategies With Lower Aerosolization
Risk
Rationale
Although the procedure of intubation carries a high risk
of aerosolization, if the patient is intubated with a cuffed
endotracheal tube and connected to a ventilator with a
high-efficiency particulate air (HEPA) filter in the path of
exhaled gas and an inline suction catheter, the resulting
closed circuit carries a lower risk of aerosolization than
any other form of positive-pressure ventilation.12
Strategies
5. Attach a HEPA filter securely, if available, to any
manual or mechanical ventilation device in the
path of exhaled gas before administering any
breaths.
6. After healthcare providers assess the rhythm and
defibrillate any ventricular arrhythmias, patients in
cardiac arrest should be intubated with a cuffed
tube at the earliest feasible opportunity. Connect
the endotracheal tube to a ventilator with a HEPA
filter when available.
7. Minimize the likelihood of failed intubation
attempts by the following:
a. Assigning the provider and approach with
the best chance of first-pass success to
intubate
b. Pausing chest compressions to intubate
8. Video laryngoscopy may reduce intubator exposure to aerosolized particles and should be considered if available.
9. Before intubation, use a bag-mask device (or T
piece in neonates) with a HEPA filter and a tight
seal, or, for adults, consider passive oxygenation
with a nonrebreathing face mask covered by a
surgical mask.
10. If intubation is delayed, consider manual ventilation with a supraglottic airway or bag-mask
device with a HEPA filter.
11. Once on a closed circuit, minimize disconnections
to reduce aerosolization.

Consider the Appropriateness of Starting
and Continuing Resuscitation
Rationale
• CPR is a high-intensity team effort that diverts rescuer attention away from other patients.13 In the
context of COVID-19, the risk to the clinical team
is increased and resources can be profoundly more
limited, particularly in regions that are experiencing
a high burden of disease. Although the outcomes
for cardiac arrest in COVID-19 are still unknown,
the mortality for critically ill patients with COVID-19
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463
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Figure 1. Summary of adjustments to cardiopulmonary resuscitation (CPR) algorithms in patients with suspected or confirmed coronavirus disease
2019 (COVID-19).
HEPA indicates high-efficiency particulate air; and PPE, personal protective equipment.

is high and rises with increasing age and comorbidities, particularly cardiovascular disease.2,5–8
Therefore, it is reasonable to consider age, comorbidities, and severity of illness in determining the
appropriateness of resuscitation and to balance the
likelihood of success against the risk to rescuers and
patients from whom resources are being diverted.14
Strategies
12. Address goals of care with patients with COVID19 (or proxy) in anticipation of the potential need
for increased levels of care.
13. Healthcare systems and EMS agencies should
institute policies to guide frontline providers in
determining the appropriateness of starting and
terminating CPR for patients with COVID-19, taking into account patient risk factors to estimate
the likelihood of survival. Risk stratification and
policies should be communicated to patients (or
proxy) during discussions of goals of care.
14. There are insufficient data to support extracorporeal CPR for patients with COVID-19.
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463

ALGORITHMS WITH KEY CHANGES
Figures 2 through 6 reflect COVID-19–specific updates
to the current basic life support, advanced cardiovascular life support, pediatric basic life support, and pediatric cardiac arrest algorithms and are meant to replace
the standard algorithms in patients with suspected or
confirmed COVID-19 disease. In COVID-19–negative
patients or when COVID-19 is not suspected, cardiac
arrest resuscitations should proceed according to the
standard algorithms. New boxes specific to COVID-19
are in yellow, and new guidance specific to COVID-19
is bolded and underlined.

SITUATION- AND SETTING-SPECIFIC
CONSIDERATIONS
Out-of-Hospital Cardiac Arrest
Below are specific considerations for cardiac arrest in
individuals with suspected or confirmed COVID-19
occurring outside of the hospital. Depending on local
June 23/30, 2020
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Figure 2. Basic life support healthcare provider adult cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019
(COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.

prevalence and evidence of community spread, COVID-19 may be suspected in some out-of-hospital cardiac
arrests.
Lay Rescuers
Bystander CPR has consistently been shown to improve
the likelihood of survival from out-of-hospital cardiac

arrest, which decreases with every minute that CPR and
defibrillation are delayed.15–17 Rescuers in the community
are unlikely to have access to adequate PPE and therefore
may be at increased risk of exposure to COVID-19 during
CPR compared with healthcare providers with adequate
PPE. Rescuers with increasing age and the presence of

e936
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Figure 3. Advanced cardiac life support cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019 (COVID-19).
CPR indicates cardiopulmonary resuscitation; ET, endotracheal; PEA, pulseless electric activity; Petco2, end-tidal carbon dioxide; PPE, personal protective equipment;
pVT, pulseless ventricular tachycardia; ROSC, return of spontaneous circulation; and VF, ventricular fibrillation.

comorbid conditions such as heart disease, diabetes mellitus, hypertension, and chronic lung disease4 are at increased risk of becoming critically ill if infected with severe
acute respiratory syndrome coronavirus 2. However, when
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463

the cardiac arrest occurs at home (as has been reported in
70% of out-of-hospital cardiac arrests17 before the recent
widespread shelter-at-home ordinances), lay rescuers are
likely to have already been exposed to COVID-19.
June 23/30, 2020
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Figure 4. Basic life support healthcare provider pediatric cardiac arrest algorithm for the single rescuer for patients with suspected or confirmed
coronavirus disease 2019 (COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.

Chest Compressions
• For adults: Lay rescuers should perform at least
hands-only CPR after recognition of a cardiac
arrest event, if willing and able, especially if they
are household members who have been exposed
to the patient at home. A face mask or cloth covering the mouth and nose of the rescuer and/or
patient may reduce the risk of transmission to a
nonhousehold bystander.
e938
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• For children: Lay rescuers should perform chest
compressions and consider mouth-to-mouth
ventilation, if willing and able, given the higher
incidence of respiratory arrest in children,17 especially if they are household members who have
been exposed to the patient at home. A face
mask or cloth covering the mouth and nose of
the rescuer and/or patient may reduce the risk
of transmission to a nonhousehold bystander if
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463
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Figure 5. Basic life support healthcare provider pediatric cardiac arrest algorithm for ≥2 rescuers for patients with suspected or confirmed coronavirus disease 2019 (COVID-19).
AED indicates automated external defibrillator; ALS, advanced life support; CPR, cardiopulmonary resuscitation; and PPE, personal protective equipment.

unable or unwilling to perform mouth-to-mouth
ventilation.
Public-Access Defibrillation
• Because defibrillation is not expected to be a highly
aerosolizing procedure, lay rescuers should use an
automated external defibrillator, if available, to assess
and treat patients with out-of-hospital cardiac arrest.
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463

EMS
Transport
• Family members and other contacts of patients
with suspected or confirmed COVID-19 should not
ride in the transport vehicle.
• If return of spontaneous circulation has not been
achieved after appropriate resuscitation efforts in
June 23/30, 2020

e939

Interim Guidance for Life Support for COVID-19

STATE OF THE ART

Edelson et al

Figure 6. Pediatric cardiac arrest algorithm for patients with suspected or confirmed coronavirus disease 2019 (COVID-19).
CPR indicates cardiopulmonary resuscitation; ET, endotracheal; PEA, pulseless electric activity; PPE, personal protective equipment; pVT, pulseless ventricular tachycardia; ROSC, return of spontaneous circulation; and VF, ventricular fibrillation.
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In-Hospital Cardiac Arrest
Below are specific considerations for patients with
suspected or confirmed COVID-19 in the hospital
setting. These interim guidelines do not apply to
patients who are known to be COVID-19 negative.
Those patients should receive standard basic and advanced life support. However, it may be reasonable
to reduce the number of personnel in the room for
all resuscitations during the pandemic for social distancing purposes.
Prearrest
• Address advanced care directives and goals of
care with all patients with suspected or confirmed
COVID-19 (or proxy) on hospital arrival and with
any significant change in clinical status such as an
increase in level of care.
• Closely monitor for signs and symptoms of clinical deterioration to minimize the need for emergency intubations that put patients and providers
at higher risk.
• If the patient is at risk for cardiac arrest, consider
proactively moving the patient to a negative-pressure room/unit, if available, to minimize risk of
exposure to rescuers during a resuscitation.
• Close the door when possible to prevent airborne
contamination of adjacent indoor space.
Intubated Patients at the Time of Cardiac Arrest
• Consider leaving the patient on a mechanical ventilator with a HEPA filter to maintain a closed circuit and to reduce aerosolization.
• Adjust the ventilator settings to allow asynchronous
ventilation (time chest compressions with ventilation
in newborns). Consider the following suggestions:
– Increase the Fio2 to 1.0.
– Use either pressure or volume control ventilation and limit pressure or tidal volume to
generate adequate chest rise (4-6 mL/kg ideal
body weight is often targeted [6mL/kg for
adults]).
– Adjust the trigger to “off” to prevent the
ventilator from autotriggering with chest
compressions and possibly prevent hyperventilation and air trapping.
– Adjust respiratory rate to 10 breaths/min for
adults and pediatrics and 30 breaths/min for
neonates.
– Assess the need to adjust the positive endexpiratory pressure level to balance lung volumes and venous return.
Circulation. 2020;141:e933–e943. DOI: 10.1161/CIRCULATIONAHA.120.047463

– Adjust alarms to deliver full breaths with
asynchronous chest compressions.
– Ensure endotracheal tube/tracheostomy
and ventilator circuit security to prevent
unplanned extubation.
• If return of spontaneous circulation is achieved, set
ventilator settings as appropriate to patients’ clinical condition.
Prone Patients at the Time of Arrest
• For patients with suspected or confirmed COVID19 who are in a prone position without an
advanced airway, attempt to place in the supine
position for continued resuscitation.
• Although the effectiveness of CPR in the prone
position is not completely known, for those
patients who are in the prone position with an
advanced airway, it may be reasonable to avoid
turning the patient to the supine position, unless
able to do so without risk of equipment disconnections and aerosolization. If unable to safely transition the patient to a supine position, place the
defibrillator pads in the anterior-posterior position
and provide CPR with the patient remaining prone
with hands in the standard position over the T7/10
vertebral bodies.18
Postarrest Patients
• Consult local infection control practices concerning transport after resuscitation.

Maternal and Neonatal Considerations
Neonatal Resuscitation
Every newly born baby should have a skilled attendant
prepared to resuscitate regardless of COVID-19 status.
Although it remains unclear if newly born babies are
infected or likely to be infectious when mothers have
suspected or confirmed COVID-19, providers should
don appropriate PPE. The mother is a potential source
of aerosolization for the neonatal team.
• Initial steps: Routine neonatal care and the initial
steps of neonatal resuscitation are unlikely to be
aerosol generating; they include drying, tactile
stimulation, placement into a plastic bag or wrap,
assessment of heart rate, and placement of pulse
oximetry and electrocardiographic leads.
• Suction: Suction of the airway after delivery should
not be performed routinely for clear or meconiumstained amniotic fluid. Suctioning is an aerosolgenerating procedure and is not indicated for
uncomplicated deliveries.
• Endotracheal medications: Endotracheal instillation of medications such as surfactant or epinephrine is an aerosol-generating procedure, especially
via an uncuffed tube. Intravenous delivery of epinephrine via a low-lying umbilical venous catheter
June 23/30, 2020
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the field, consider not transferring to hospital given
the low likelihood of survival for the patient,17 balanced against the added risk of additional exposure to prehospital and hospital providers.
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is the preferred route of administration during
neonatal resuscitation.
• Closed incubators: Closed incubator transfer and
care (with appropriate distancing) should be used
for neonatal intensive care patients when possible
but do not protect against aerosolization of virus.
Maternal Cardiac Arrest
The tenets of maternal cardiac arrest are unchanged for
women with suspected or confirmed COVID-19.
• The cardiopulmonary physiological changes of
pregnancy may increase the risk of acute decompensation in critically ill pregnant patients with
COVID-19.
• Preparation for perimortem delivery, to occur after
4 minutes of resuscitation, should be initiated early
in the resuscitation algorithm to allow the assembly of obstetric and neonatal teams with PPE even
if return of spontaneous circulation is achieved
and perimortem delivery is not required.

Interim Guidance for Life Support for COVID-19
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